|
PTPN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.098000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.223600E-01 |
| Normal-vs-Stage2 |
2.190200E-02 |
| Normal-vs-Stage3 |
4.285800E-01 |
| Normal-vs-Stage4 |
8.217200E-01 |
| Stage1-vs-Stage2 |
2.059800E-03 |
| Stage1-vs-Stage3 |
1.699640E-01 |
| Stage1-vs-Stage4 |
9.337400E-01 |
| Stage2-vs-Stage3 |
7.098200E-02 |
| Stage2-vs-Stage4 |
1.428090E-02 |
| Stage3-vs-Stage4 |
3.135800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.491600E-01 |
| Normal-vs-AfricanAmerican |
5.879600E-01 |
| Normal-vs-Asian |
6.002800E-01 |
| Caucasian-vs-AfricanAmerican |
6.441800E-01 |
| Caucasian-vs-Asian |
6.055800E-01 |
| AfricanAmerican-vs-Asian |
9.419800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.031800E-01 |
| Normal-vs-Female |
7.863400E-01 |
| Male-vs-Female |
7.048200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.456000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.808800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.317600E-02 |
| Normal-vs-Age(81-100Yrs) |
8.587600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.651150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.156150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.126200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.616400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.984400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.212000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.441430E-01 |
| Classical-VS-Follicular |
1.04809999568189E-08 |
| Classical-VS-Other |
6.432600E-01 |
| Classical-VS-Normal |
1.994370E-01 |
| Tall-VS-Follicular |
3.582400E-03 |
| Tall-VS-Other |
8.016600E-01 |
| Tall-VS-Normal |
6.890800E-01 |
| Follicular-VS-Other |
1.399780E-01 |
| Follicular-VS-Normal |
1.750300E-04 |
| Other-VS-Normal |
9.678200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.334620E-01 |
| Normal-vs-N1 |
3.480600E-01 |
| N0-vs-N1 |
7.933200E-01 |
|
|
